In 310 children aged 4–18 on highly emetogenic chemotherapy, olanzapine instead of dexamethasone (both with palonosetron and fosaprepitant) was noninferior for complete vomiting control (63.5% vs 56.9%), but caused more somnolence (50.7% vs 17.2%).
RCTn = 310
Radhakrishnan et al. Dexamethasone-Free Antiemetic Prophylaxis for Children and Adolescents Receiving Highly Emetogenic Chemotherapy: A Multicenter, Phase III, Noninferiority Trial (CIVIC POD)